Moderna Inc. shares are selling off Wednesday, after the Trump administration took aim at the science behind the biotechnology company’s vaccines and said it would cancel some contracts and stop ...

Teams that bring a variety of experience and expertise can spot problems faster and arrive at more well-rounded, viable solutions. They can think beyond their own blind spots.

Moderna ( ($MRNA) ) has risen by 10.01%. Read on to learn why. Moderna’s stock has experienced a notable increase of 10.01% over the past week, ...

The Nobel Prize-winning technology underpinning COVID-19 vaccines is also fueling a host of biotechs developing treatments ...

Illinois researchers, including some working on vaccines for cancer and rare diseases, worry the federal government turning ...

With that in mind, let's consider two stocks that people in their 30s -- who are still a good distance away from retirement - ...

Influenza Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical ...

Under Robert F. Kennedy Jr., federal officials may withdraw an endorsement for the vaccine in younger children.

Moderna’s expected 400% hike for its COVID vaccine sparked outrage on Capitol Hill. The pharmaceutical giant could raise the price of the vaccine from its current $26 per dose to between $110 ...

The United States paid $15 to $16.50 for each shot, on top of the $1.3 billion the government gave Moderna to develop its vaccine. The European Union has paid $22.60 to $25.50 for its Moderna doses.

Moderna has hired a former FBI agent to compile internal company reports about “high-risk” celebrities — including tennis star Novak Djokovic, tech mogul Elon Musk and actor Russe… ...